Neuphoria Therapeutics Inc. (NEUP) NASDAQ

7.02

-0.08(-1.13%)

Updated at July 01 04:00PM

Currency In USD

Valuation

Market Cap1.24B
Enterprise Value1.23B
P/E Ratio286.41
PEG Ratio2.27
Price/Sales Ratio0.84
Price/Book Ratio63.19
Enterprise/Revenue-0.23
Enterprise/EBITDA-0.77

Fiscal Year

Fiscal YearJune 30, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.37
Operating Margin0.15

Management Effectiveness

Return On Assets0.19
Return On Equity0.31

Income Statement

Revenue0
Revenue/Share0.07
Gross Profit0
EBITDA-17.13M
Net Income-15.49M
Diluted EPS-0.1

Balance Sheet

Total Cash17.05M
Total Cash/Share0.07
Total Debt172,460
Total Debt/Equity0.01
Current Ratio11.01
Book Value Per Share0.11

Price History

52-Week Change-15.22
52-Week High12.55
52-Week Low2.12
Moving Average 50 Days6
Moving Average 200 Days4.86

Statistics

Average Volume23,040
Shares Outstanding1.88M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:12
Last Split DateDecember 24, 2024